To: | Rhythm Pharmaceuticals, Inc. (trademarks@morganlewis.com) |
Subject: | U.S. Trademark Registration No. 88421834 - RHYTHM - 114020-0009 |
Sent: | 02/21/20 07:58:20 AM |
Sent As: | ecomitu@uspto.gov |
Attachments: |
United States Patent and Trademark Office (USPTO)
U.S. Application Serial No. 88421834
Mark: RHYTHM
|
|
Correspondence Address: |
|
Applicant: Rhythm Pharmaceuticals, Inc.
|
|
Reference/Docket No. 114020-0009
Correspondence Email Address: |
|
NOTICE THAT PROCESSING OF
REQUEST TO DIVIDE APPLICATION IS COMPLETED
No Response Required
Issue date: February 21, 2020
The request to divide application serial no. 88421834 filed on January 22, 2020 has been processed as follows:
(1) Parent (original) application serial no. 88421834 contains the following goods in class(es):
5 (Pharmaceuticals and medicines for the treatment of metabolic diseases and disorders, including obesity, diabetes, metabolic syndrome and cachexia, and gastrointestinal diseases and disorders, including gastroparesis, post-operative ileus, chronic constipation, and inflammatory bowel disease).
To avoid abandonment, applicant must continue to file requests for extension of time to file a statement of use (extension requests) or a statement of use within the six-month period after the issuance of the notice of allowance or before expiration of a previously granted extension period. 37 C.F.R. §§2.88(a), 2.89(a)-(b).
(2) Child application serial no. 88976878 contains the following services in class(es):
42 (Research and product development services in the fields of metabolic diseases and disorders, including obesity, diabetes, metabolic syndrome and cachexia, and gastrointestinal diseases and disorders, including gastroparesis, post-operative ileus, chronic constipation, and inflammatory bowel disease).
A statement of use filed on January 22, 2020 meets the minimum filing requirements and has been placed in the child application. The statement of use will be routed to the examining attorney for examination and, if it does not meet all the statutory requirements, the examining attorney will notify the applicant.
37 C.F.R. §2.87; see TMEP §§1110 et seq.
Direct questions about this notice to the assigned Intent-to-use staff member below.
/Tracy Welch/
Tracy Welch
Paralegal Specialist
OFC OF TM SVC
ITU/Divisional Unit
571-272-9631
tracy.welch@uspto.gov